Document Detail


Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis.
MedLine Citation:
PMID:  19863881     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The recombinant human epoetin-a HX575 (Sandoz Pharmaceuticals GmbH/Hexal AG, Holzkirchen, Germany) is the first biosimilar erythropoiesis-stimulating agent (ESA) with marketing authorization in Europe. The primary objective of the study was the evaluation of therapeutic equivalence in terms of hemoglobin (Hb) response of HX575 compared with the comparator product (EPREX/ ERYPO, Janssen-Cilag/Ortho Biotech, Neuss, Germany) in the long-term intravenous (i.v.) treatment of anemia in chronic renal failure patients on hemodialysis following a 1 : 1 dose conversion from the comparator product to HX575. METHODS: Hemodialysis patients with Hb levels of 10.0 - 13.0 g/dl were randomized to either continue their current i.v. epoetin-a treatment or switch to HX575. During treatment, epoetin dosages were titrated to maintain Hb values. The primary endpoint was the difference between treatment groups in the mean absolute change of Hb levels between baseline and evaluation period (Weeks 25 - 28). RESULTS: Therapeutic equivalence of HX575 and the comparator epoetin-alpha, assessed during the evaluation period, was statistically confirmed: mean changes in Hb levels were 0.15 +/- 0.09 g/dl in the HX575 and 0.06 +/- 0.12 g/dl in the comparator epoetin-a group, with a difference between groups of 0.08 g/dl (95% confidence interval: -0.17; 0.34). Hb levels and epoetin dosages remained stable throughout the entire study period of 56 weeks. The long-term safety profile of HX575 was similar to that of the comparator epoetin-alpha. No antibody formation was detected. CONCLUSIONS: The study demonstrated therapeutic equivalence of biosimilar HX575 to the comparator epoetin-a, together with a comparable safety profile.
Authors:
M Haag-Weber; A Vetter; U Thyroff-Friesinger;
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical nephrology     Volume:  72     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-29     Completed Date:  2010-01-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  380-90     Citation Subset:  IM    
Affiliation:
Kuratorium f??r Dialyse und Nierentransplantation e.V., Straubing, Germany. marianne.haag-weber@kfh-dialyse.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Anemia / blood,  drug therapy*,  etiology
Double-Blind Method
Epoetin Alfa / adverse effects,  therapeutic use*
Female
Hematinics / adverse effects,  therapeutic use*
Hemoglobins / analysis
Humans
Kidney Failure, Chronic / complications*,  therapy
Male
Middle Aged
Renal Dialysis*
Therapeutic Equivalency
Young Adult
Chemical
Reg. No./Substance:
0/HX575; 0/Hematinics; 0/Hemoglobins; 113427-24-0/Epoetin Alfa
Investigator
Investigator/Affiliation:
Peter Balcke / ; Helmut Graf / ; Josef Kovarik / ; Leo M Marosi / ; Gert M Mayer / ; Ulrich Neyer / ; Hans Krister Stummvoll / ; Herwig Holzer / ; Peter Kotanko / ; Marianne Haag-Weber / ; Harald Achenbach / ; Kirsten Anding-Rost / ; Hans-Gernot Asmus / ; Patrick Biggar / ; Christof Blaser / ; Norbert Bockreiss / ; Gert-Peter Dragoun / ; Volkmar Gl??ser / ; Grit Glombig / ; Maximilian Goller / ; Hermann Haller / ; Marc Heydenreich / ; Frank Heyder / ; G??nther Kraatz / ; R??diger Krallinger / ; Rolfdieter Krause / ; Friedrich Lazarus / ; Sabine Ludewig / ; Klaus-J??rgen Lukowski / ; Thomas Meyer / ; Bernhard Riedl / ; Uwe Rothenpieler / ; Andreas Schmitt / ; Bernhard Schober / ; Heide Sperschneider / ; Walter Schulz / ; Petra Schulz / ; Bruno Spohn / ; Thomas Strack / ; Thomas Wichelhaus / ; Holger Franke / ; Bernhard Frye / ; Angelika Kirpal / ; Helmut Kr??mer / ; Gunnar Schaeffer / ; Dirk Schaumann / ; Michael T??pfer / ; G??nter Hartmann / ; J??rg Schiele / ; Michael Riedasch / ; Stefan Holzmann / ; Johann Knee / ; Matthias Anders / ; Hans-Dieter Hoffmann / ; Gerd Perschon / ; Peter Maria Rob / ; Stefan Holzmann / ; Detlev Adler / ; Martin Troeltsch / ; Norbert Heni /

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prospective studies on applications of a two-cuff Swan neck catheter and a Tenckhoff catheter to Chi...
Next Document:  A case with spontaneous bladder rupture mimicking acute kidney injury.